Y. Glupczynski

17.2k total citations · 4 hit papers
262 papers, 10.6k citations indexed

About

Y. Glupczynski is a scholar working on Molecular Medicine, Epidemiology and Endocrinology. According to data from OpenAlex, Y. Glupczynski has authored 262 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Medicine, 70 papers in Epidemiology and 61 papers in Endocrinology. Recurrent topics in Y. Glupczynski's work include Antibiotic Resistance in Bacteria (122 papers), Bacterial Identification and Susceptibility Testing (52 papers) and Antibiotics Pharmacokinetics and Efficacy (46 papers). Y. Glupczynski is often cited by papers focused on Antibiotic Resistance in Bacteria (122 papers), Bacterial Identification and Susceptibility Testing (52 papers) and Antibiotics Pharmacokinetics and Efficacy (46 papers). Y. Glupczynski collaborates with scholars based in Belgium, France and Netherlands. Y. Glupczynski's co-authors include Pierre Bogaerts, Paul M. Tulkens, Marie‐Paule Mingeot‐Leclercq, A Burette, Te‐Din Huang, C. Berhin, Françis Mégraud, Thierry Naas, Patrice Nordmann and M López-Brea and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Y. Glupczynski

256 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aminoglycosides: Activity and Resistance

1999 825 citations Y. Glupczynski, Paul M. Tulkens et al. Antimicrobial Agents and Chemotherapy profile →
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

2012 680 citations Y. Glupczynski et al. Clinical Microbiology and Infection profile →
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

2012 648 citations Françis Mégraud, Samuel Coenen et al. Gut profile →
Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community

2021 183 citations Françis Mégraud, Samuel Coenen et al. Gut profile →

Peers

Countries citing papers authored by Y. Glupczynski

Since Specialization

Citations

This map shows the geographic impact of Y. Glupczynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Glupczynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Glupczynski more than expected).

Fields of papers citing papers by Y. Glupczynski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Glupczynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Glupczynski. The network helps show where Y. Glupczynski may publish in the future.

Co-authorship network of co-authors of Y. Glupczynski

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Glupczynski. A scholar is included among the top collaborators of Y. Glupczynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Glupczynski. Y. Glupczynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of genome-wide transpositions induced by colistin exposure in multi-drug-resistant Klebsiella pneumoniae 2025 ·Antimicrobial Agents and Chemotherapy ·(unknown), Basil Britto Xavier, Minh Ngoc Nguyen, Qiang Lin, (unknown), Nienke L. Plantinga, Bastiaan HJ Wittekamp, Olympia Zarkotou, Rob Van Houdt, Y. Glupczynski, Spyros Pournaras, Marc J. M. Bonten, Surbhi Malhotra‐Kumar	0
2	Assessment of Colistin Heteroresistance among Multidrug-Resistant Klebsiella pneumoniae Isolated from Intensive Care Patients in Europe 2024 ·Antibiotics ·(unknown), (unknown), (unknown), (unknown), Christine Lammens, Y. Glupczynski, Surbhi Malhotra‐Kumar	3
3	Prospective evaluation of a high multiplexing real-time polymerase chain reaction array for the rapid identification and characterization of bacteria causative of nosocomial pneumonia from clinical specimens: a proof-of-concept study 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·Sandrine Roisin, T.-D. Huang, Ricardo De Mendonça, C. Nonhoff, Pierre Bogaerts, Maya Hites, B. Delaere, Sandrine Hamels, Florence De Longueville, Y. Glupczynski, Olivier Denis	8
4	Validation of carbapenemase and extended-spectrum -lactamase multiplex endpoint PCR assays according to ISO 15189 2013 ·Journal of Antimicrobial Chemotherapy ·Pierre Bogaerts, Roberta Rezende de Castro, Ricardo De Mendonça, Te‐Din Huang, Olivier Denis, Y. Glupczynski	104
5	Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects 2013 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), Jean‐Daniel Hecq, Paul M. Tulkens, Y. Glupczynski	32
6	Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption breakdown → 2012 ·Gut ·Françis Mégraud, Samuel Coenen, Ann Versporten, Manfred Kist, M López-Brea, Alexander M. Hirschl, Leif Percival Andersen, Herman Goossens, Y. Glupczynski, (unknown)	648
7	Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals 2011 ·International Journal of Antimicrobial Agents ·Y. Glupczynski, Te‐Din Huang, Warda Bouchahrouf, Roberta Rezende de Castro, Caroline Bauraing, Michèle Gérard, (unknown), A. Deplano, Olivier Denis, Pierre Bogaerts	106
8	Transcriptomic biomarkers of human ageing in peripheral blood mononuclear cell total RNA 2009 ·Experimental Gerontology ·(unknown), Patrice Godard, Marie de Saint‐Hubert, (unknown), (unknown), Florence Debacq‐Chainiaux, Y. Glupczynski, Christian Swine, Vincent Geenen, Henri Martens	20
9	Evaluation of a new meropenem–EDTA double-ended Etest strip for the detection of the CfiA metallo-β-lactamase in clinical isolates of Bacteroides fragilis 2008 ·Clinical Microbiology and Infection ·Pierre Bogaerts, (unknown), C. Berhin, (unknown), (unknown), (unknown), Y. Glupczynski	10
10	A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital 2006 ·Clinical Microbiology and Infection ·Laurent Blairon, Yves De Gheldre, B. Delaere, (unknown), André Bosly, Y. Glupczynski	73
11	L'efflux des antibiotiques: un mécanisme ubiquitaire conduisant à la résistance. État de la question et implications microbiologiques et cliniques 2005 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·Narcisa Mesaros, Françoise Van Bambeke, Y. Glupczynski, R. Vanhoof, Paul M. Tulkens	1
12	Comparison of the E Test and Agar Dilution Method for Antimicrobial Suceptibility Testing of Helicobacter pylori 2002 ·European Journal of Clinical Microbiology & Infectious Diseases ·Y. Glupczynski, Nathalie Broutet, (unknown), Lis Smedegaard Andersen, Tomás Alarcón, (unknown), (unknown)	88
13	A Multicentre Survey of Antimicrobial Resistance in Gram-Negative Isolates from Belgian Intensive Care Units in 1994-1995 1998 ·Acta Clinica Belgica ·Y. Glupczynski, Michel Delmée, Herman Goossens, Marc Struelens	15
14	In VitroSusceptibilities Of 176 Clinical Isolates OfStreptococcus Pneumoniae to11 Beta-Lactams, Erythromycin, and Tetracycline 1996 ·Acta Clinica Belgica ·R. Vanhoof, (unknown), Y. Glupczynski, B. Gordts, Koen Magerman, (unknown), (unknown), I. Surmont, (unknown), H. Van Landuyt, (unknown), R. Van Noyen	2
15	Prevalence of Helicobacter pylori in rural Kivu, eastern Zaire: A prospective endoscopic study 1991 ·European Journal of Gastroenterology & Hepatology ·Y. Glupczynski, (unknown), Carine Deprez, (unknown), Thierry Devreker, (unknown), Herman Goossens, (unknown), Jean‐Paul Butzler	16
16	Detection of apramycin resistant enterobacteriaceae in hospital isolates 1989 ·FEMS Microbiology Letters ·E. Chaslus-Dancla, Y. Glupczynski, G Gerbaud, (unknown), J.P. Lafont, Patrice Courvalin	23
17	Bactericidal activity of LY-163892, a new cephalosporin, against beta-lactamase-producing strains of Haemophilus influenzae compared with amoxicillin-clavulanic acid 1989 ·Current Therapeutic Research ·E. Yourassowsky, Martial Van der Linden, (unknown), F. Crokaert, Y. Glupczynski	1
18	DONNEES CLINIQUES, ENDOSCOPIQUES ET HISTOLOGIQUES CHEZ 1100 PATIENTS DONT 574 COLONISES PAR CAMPYLOBACTER PYLORI 1989 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·M. Deltenre, (unknown), (unknown), Y. Glupczynski, Carine Deprez, A Burette	11
19	Selection and counting of aerobic gram-negative bacilli in saliva by the spiral system 1987 ·European Journal of Clinical Microbiology & Infectious Diseases ·E. Yourassowsky, Mark van der Linden, (unknown), F. Crokaert, Y. Glupczynski	5
20	Activity of cefsulodin against methicillin-resistant Staphylococcus aureus 1985 ·Current Therapeutic Research ·Y. Glupczynski, F. Crokaert, Martial Van der Linden, E. Yourassowsky	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact